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Abstract: Few studies assessed the associations between dietary vitamin K and depressive symptoms.
We aimed to investigate the association between dietary vitamin K and depressive symptoms in a large
cohort of North American People. In this cross-sectional analysis, 4,375 participants that were aged
45–79 years from the Osteoarthritis Initiative were included. Dietary vitamin K intake was collected
through a semi-quantitative food frequency questionnaire and categorized in quartiles. Depressive
symptoms were diagnosed using the 20-item Center for Epidemiologic Studies-Depression (CES-D)
≥ 16. To investigate the associations between vitamin K intake and depressive symptoms, logistic
regression analysis were run, which adjusted for potential confounders. Overall, 437 (=10%) subjects
had depressive symptoms. After adjusting for 11 confounders, people with the highest dietary
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vitamin K intake had lower odds of having depressive symptoms (OR = 0.58; 95%CI: 0.43–0.80). This
effect was only present in people not taking vitamin D supplementation. In conclusion, higher dietary
vitamin K intake was significantly associated with a lower presence of depressive symptoms, also
after accounting for potential confounders. Future longitudinal research is required to explore the
directionality of the association.
Keywords: vitamin K; depression; Osteoarthritis Initiative; mental health; diet; nutrition
1. Introduction
The prevalence of depressive disorders among old people in the United States is approximately
4.5% [1]. Late life depression significantly decreases the quality of life [2] and it is often accompanied
by significant medical burden and disability [2]. Moreover, it is related to significantly increased risk
of stroke [3], myocardial infarction [4], and finally mortality [3]. Although major depression is a very
common disease, the pathogenesis is still presently unknown. Depression in the elderly is complex
and it may occur for various reasons and under different conditions. It has already been pointed out
that diet and nutrition, particularly vitamins, may influence depression [5].
Being especially known for its role in blood coagulation, there is now evidence that vitamin K
has important actions in the nervous system. In particular, it has been implicated in the regulation of
sphingolipid metabolism and in protection against oxidative stress in the brain [6]. Notably, it has been
demonstrated that vitamin K concentrations in the brain are influenced by diet in a way that reflects its
intake, even if these findings are limited to a few animal models [7]. On the other hand, concerns have
been expressed that the current recommended intake of vitamin K (120 ug/d for men and 90 ug/d
for women) might not provide sufficient amounts for fulfilling all the functions of vitamin K proteins
beyond those that are involved in coagulation [8].
In a previous study, vitamin K deficiency, as induced by dietary depletion or by warfarin treatment,
was associated with hypoactivity and a lack of exploratory behavior in rats [9]. Moreover, in another
study, vitamin K supplementation antagonized depression-like behavior in rats with a dietary model
of metabolic syndrome [10]. Currently, there are only two studies on human beings, with contrasting
results to the best of our knowledge. Recently, a Japanese team examined the relationship between
vitamin K intake and depressive symptoms in elderly people, finding a positive relation between
low vitamin K intake and depression [5]. On the contrary, a study in Spanish children found no such
association [11].
Given this background, the aim of the present study was to investigate the association between
vitamin K intake and the presence of depressive symptoms in a large cohort of older adults that
reside in North America who are at risk of or who have osteoarthritis. Based on previous studies, we
hypothesized that persons with higher intake of vitamin K would be at a lower risk of presenting
depressive symptoms.
2. Materials and Methods
2.1. Data Source and Subjects
The Osteoarthritis Initiative database [12] is available for public access at http://www.oai.ucsf.
edu/. The specific datasets that were utilized were registered during the baseline and screening
evaluations (V00). The OAI (Osteoarthritis Initiative) includes people at high risk of knee osteoarthritis
or having knee osteoarthritis, who were recruited at four clinical centers in the USA (Baltimore, MD,
USA; Pittsburgh, PA, USA; Pawtucket, RI, USA; and, Columbus, OH, USA) between February 2004 and
May 2006. People were eligible if they: i) had knee osteoarthritis and reported knee pain in a 30-day
period in the past 12 months or ii) were at high risk of developing knee OA (e.g., overweight/obese,
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knee injury/operation, parents/siblings with total knee replacement, frequent knee-bending activities
that increase risk, and hand/hip osteoarthritis) [12].
All of the participants provided written informed consent. The Osteoarthritis Initiative study
protocol was approved by the institutional review board of the Osteoarthritis Initiative Coordinating
Center, University of California at San Francisco.
2.2. Dietary Vitamin K Intake (Exposure)
The semi-quantitative Block Brief 2000 food frequency questionnaire (FFQ) at baseline, which is a
validated and widely used method [13,14], was used for collecting information regarding dietary habits
over the previous year. This validated tool contains a food list of 70 items and it was designed to assess
the individual’s food and beverage consumption over the past year, including the consumption of
supplements. Frequency of food consumption of the included items was reported at nine levels (“never”
to “every day”). The vitamin K intake was then calculated as the sum of vitamin K supplementation
(if any) and of dietary intake of vitamin K, as assessed by the diet recall questionnaire, the Block Brief
2000 FFQ. NutritionQuest (http://www.nutritionquest.com/assessment/), using standard values for
amounts of vitamin K across an array of foods automatically calculated the Vitamin K scores for this
study. The foods with particularly high reference levels of vitamin K are leafy vegetables, such as kale,
broccoli, and spinach, with lower (but still notable) levels in fruits and berries and fish.
Dietary vitamin K intake was arbitrarily categorized in four quartiles while using the following
cut-offs: 83, 138, 232 ug/day. Moreover, we modelled the dietary vitamin K intake as per
100 ug/day increment.
2.3. Outcome (Depressive Symptoms)
The presence of depressive symptoms was assessed from the 20-item Center for Epidemiologic
Studies-Depression (CES-D) instrument [15]. The range of possible values for this scores is 0 to 60,
where higher scores indicate more depressive symptoms [15]. A cut-off of 16 was used for the presence
of depressive symptoms [16].
2.4. Covariates
We identified numerous potential confounders that may influence the relationship between
dietary vitamin K and depressive symptoms, including: body mass index (BMI), as measured by a
trained nurse; total energy intake (in Kcal); physical activity evaluated using the Physical Activity
Scale for the Elderly (PASE) [17]; ethnicity; smoking habits, educational level and yearly income
(< or ≥$50,000 or missing data); self-reported comorbidities that were assessed using the modified
Charlson comorbidity score [18]; and, adherence to Mediterranean diet according to the score that was
suggested by Panagiotakos et al. [19] and already reported in the OAI [14,20–22]. Data regarding diet,
physical activity, demographics and comorbidities were recorded through questionnaires given to the
participants. The covariates that were included in the multivariate analysis were those significantly
different across dietary vitamin K quartiles (considering a p-value < 0.10) or significantly associated
with depressive symptoms, according to a univariate analysis (p-value < 0.05).
2.5. Statistical Analyses
The normal distributions of continuous variables were tested using the Kolmogorov–Smirnov test.
Data are shown as means± standard deviations (SDs) for quantitative measures and the frequency and
percentages for all discrete variables. For skewed distributions, the data were reported as median with
the interquartile range, IQR. The P values for trends were calculated using the Jonckheere–Terpstra
test for continuous variables and the Mantel–Haenszel Chi-square test for categorical variables.
Several tests assessed the association between dietary vitamin K intake and depressive symptoms.
First, we compared the mean values of CES-D across dietary vitamin K intake quartiles, using the
p for trend for continuous variables. Second, we compared the dietary vitamin K intake between
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those with depressive symptoms vs. those without, while using an independent T-test. Finally, we
used a logistic regression analysis using as exposure dietary vitamin K (categorized in quartiles or for
each 100 ug/day increase) and as outcome the presence of depressive symptoms. The basic model
was adjusted for age and sex. In addition to age and sex, the fully adjusted model, adjusted for:
ethnicity (whites vs. others); BMI (as continuous); education (degree vs. others); smoking habits
(current and previous vs. others); yearly income (categorized as ≥ or <50,000$, missing data); PASE
(as continuous); Charlson co-morbidity index (as continuous); daily energy intake (as continuous);
and, adherence to Mediterranean diet (as continuous). In all of the analyses, logistic regression data
are reported as odds ratios (ORs) with 95% confidence intervals (CIs). Multi-collinearity among the
covariates was assessed using the variance inflation factor (VIF), with a score of 2, leading to the
exclusion of vitamin D supplementation, which had a high VIF with adherence to the Mediterranean
diet (VIF = 2.13). In our analyses, we kept adherence to the Mediterranean diet as a covariate, since
the strength of the association between depressive symptoms and adherence to Mediterranean diet
was greater than that of vitamin D supplementation. We also explored in sensitivity analyses if gender
(p = 0.08), BMI (categorized as overweight/obese vs. others) (p = 0.88), or vitamin D supplementation
(test for interaction with a logistic regression analysis p < 0.001) can affect our results. Finally, a simple
correlation analysis (Pearson’s coefficient) and a linear regression analysis were used and reported as
R and standardized betas, respectively.
All of the analyses were performed using SPSS 17.0 for Windows (SPSS Inc., Chicago, IL, USA).
All of the statistical tests were two-tailed and statistical significance was assumed for a p-value < 0.05.
3. Results
3.1. Sample Selection
The Osteoarthritis Initiative dataset initially included a total of 4,796 North American participants.
At the baseline, we excluded 65 individuals, since they did not have data regarding depressive
symptoms, 99 did not have data regarding their dietary vitamin K intake, and 257 with an implausible
calorie intake (less than 800/greater than 4200 Kcal for men less than 500/greater than 3800 for women).
Therefore, 4375 people were finally included in this research.
In order to determine how representative our included sample was, we assessed for significant
demographic and/or lifestyle differences between the included (n = 4375) and excluded (n = 421)
participants. Excluded people did not differ in terms of mean age (p = 0.48), female gender prevalence
(p = 0.29), depressive symptoms (in those missing vitamin K information, p = 0.84), or vitamin K intake
(p = 0.28).
3.2. Descriptive Characteristics
Of the 4375 participants, 2538 were females and 1837 males. The mean age was 61.3 years
(±9.2 years; range: 45–79). The median dietary vitamin K intake was 138 (IQR: 83–232) ug/day.
Table 1 shows the participants’ characteristics by their dietary vitamin K intake. Those that were
consuming more vitamin K (>232 ug/day) were more active, had a higher adherence to Mediterranean
diet, consumed fruits, vegetables, and dairy products more frequently, and were more likely to be
female, smokers, vitamin D supplementation consumers, and non-white than their counterparts
(Table 1). On the contrary, no association between dietary vitamin K intake and age, education, income,
BMI, or the presence of co-morbidity was found (Table 1).
3.3. Dietary Vitamin K Intake and Depressive Symptoms
As shown in Table 1, subjects having a higher dietary vitamin K intake had significantly lower
mean values of CESD (p for trend = 0.002).
In the sample as whole, 437 (=10.0%) reported the presence of depressive symptoms. People
with depressive symptoms reported significantly lower dietary vitamin K intake (165 ± 132 ug/day)
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when compared to those not having depressive symptoms (n = 3938) (185 ± 164 ug/day) (p = 0.001)
(Figure 1).
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Figure 1. The data are reported as means with their standard deviations. Left column = individuals
with depressive symptoms; right column = individuals without depressive symptoms.
As shown in Table 2, the prevalence of depressive symptoms was significantly lower in people
with higher dietary vitamin K intake (9.1% in those with a dietary vitamin K > 232 ug/day vs. 11.9%
in those with <83 ug/day; p = 0.03). In the logist c regr ssion analysis, after a justing for 11 potential
confounders and while t king p ople with lower dietary vitamin K intak as reference, people with
the highest dietary vitamin K intake had signific nt lower odds of having depressive symptoms
of about 42% (OR = 0.58; 95%CI: 0.43–0.80; p = 0.001) (Table 2). Each increase in 100 ug of diet ry
vita in K intake was assoc ated with sig ificant lower odds of 12% (OR = 0.88; 95%CI: 0.82–0.95;
p = 0.001) (p for trend = 0.003). However, his effect was only present in people not taking vitamin
D as supplementation. In the people not taking vitamin D supplementation (n = 3166), in fact, we
observed a significant lower odds of depressive symptoms in thos having a higher vitamin K intake
(Q4) (OR = 0.61; 95%CI: 0.43–0.88; p = 0.008), whilst the associ tion between vitamin K intake and
depression in those taking vitamin D suppl mentation (n = 1209) was not si nificant (Q4: OR = 0.72;
95%CI: 0.38–1.34; p = 0.28). Each increase in 100 ug o dietary vitamin K intake wa o ly associated
with a significant low r odds of 18% (OR = 0.82; 95%CI: 0.78–0.86; p < 0.001) (p f r trend < 0.001) in
people not taking vitamin D supplementation.
Finally, we observ d a we k negative correla ion between die ary vitamin K intake a d d pressive
symptoms (r =−0.15; p = 0.03), as confirmed by a line r regression analysis (s andardized beta =−0.10;
95%CI: −0.17 to −0.03; p = 0.02).
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Table 1. Characteristics of the participants classified according to their dietary vitamin K intake.
Vitamin K <83 µg (n = 1094) Vitamin K 83–138 µg (n = 1094) Vitamin K 139–232 µg (n = 1094) Vitamin K > 232 µg (n = 1093) p Value for Trend 1
Energy intake (Kcal/day) 1222 (455) 1377 (487) 1479 (536) 1642 (621) <0.001
Fiber (g/day) 4.1 (2.2) 6.1 (2.4) 8.1 (2.8) 12.5 (5.2) <0.001
Fruits (servings/day) 1.12 (0.77) 1.43 (0.83) 1.58 (0.89) 1.72 (0.97) <0.001
Vegetables (servings/day) 1.47 (0.77) 2.48 (0.88) 3.62 (1.20) 6.05 (2.61) <0.001
Dairy (servings/day) 1.25 (0.95) 1.35 (0.93) 1.42 (0.97) 1.44 (1.03) <0.001
aMED (points) 26 (5) 28 (6) 29 (5) 30 (5) <0.001
Age (years) 60.1 (9.5) 61.5 (9.1) 61.6 (9.4) 61.0 (8.8) 0.21
PASE (points) 156 (81) 158 (79) 161 (82) 167 (84) 0.007
Females (n, %) 546 (49.9) 595 (54.4) 657 (60.1) 740 (67.7) <0.001
White race (n, %) 898 (82.2) 929 (84.9) 898 (82.2) 790 (72.3) <0.001
Smoking (previous/current) (n, %) 489 (45.0) 488 (44.9) 527 (48.3) 560 (51.5) 0.001
Graduate degree (n, %) 291 (26.6) 363 (33.2) 332 (30.4) 341 (31.2) 0.07
Yearly income (≥$50,000) 613 (56.0) 650 (59.4) 686 (62.7) 635 (58.1) 0.13
Vitamin D supplementation (n, %) 228 (21.2) 292 (27.1) 332 (30.9) 357 (33.0) <0.001
BMI (Kg/m2) 28.5 (4.7) 28.7 (4.8) 28.6 (4.8) 28.9 (4.9) 0.34
Charlson co-morbidity index (points) 0.41 (0.91) 0.40 (0.87) 0.37 (0.79) 0.39 (0.79) 0.58
CESD points (SD) 7.3 (7.8) 6.3 (6.7) 6.4 (6.5) 6.4 (6.8) 0.002
Notes: The data are presented as means (with standard deviations) for continuous variables and number (with percentage). 1 p values for trends were calculated using the
Jonckheere-Terpstra test for continuous variables and the Mantel-Haenszel Chi-square test for categorical variables. Abbreviations: aMED: adherence to Mediterranean diet; BMI: body
mass index; CESD: Center for Epidemiologic Studies-Depression; PASE: Physical Activity Scale for the Elderly.
Table 2. Association between dietary vitamin K intake and depressive symptoms.
Whole Sample (n = 4375) Not Taking Vitamin D Supplementation (n = 3166) Taking Vitamin D Supplementation (n = 1209)
Prevalence
Depressive
Symptoms
(%)
Basic-Adjusted 1
OR
(95%CI)
p Value
Fully-Adjusted 2
OR
(95%CI)
p Value
Basic-Adjusted 1
OR
(95%CI)
p Value
Fully-Adjusted 2
OR
(95%CI)
p Value
Basic-Adjusted
OR
(95%CI)
p Value
Fully-Adjusted 2
OR
(95%CI)
p Value
Vitamin K <83 µg 130/1094(=11.9)
1 [reference]
[p for trend = 0.04]
1 [reference]
[p for trend = 0.02]
1 [reference]
[p for trend = 0.03]
1 [reference]
[p for trend = 0.02]
1 [reference]
[p for trend = 0.07]
1 [reference]
[p for trend = 0.08]
Vitamin K
83–138 µg
105/1094
(=9.6) 0.79 (0.60–1.04) 0.10 0.80 (0.60–1.07) 0.13 0.66 (0.47–0.92) 0.01 0.65 (0.46–0.93) 0.02 1.24 (0.70–2.20) 0.45 1.15 (0.63–2.10) 0.65
Vitamin K
139–232 µg
102/1094
(=9.3) 0.74 (0.56–0.98) 0.04 0.76 (0.57–1.03) 0.08 0.80 (0.58–1.11) 0.18 0.85 (0.59–1.21) 0.36 0.64 (0.34–1.20) 0.17 0.52 (0.26–1.03) 0.06
Vitamin K >232 µg 100/1093(=9.1) 0.67 (0.51–0.89) 0.006 0.58 (0.42–0.81) 0.001 0.64 (0.45–0.90) 0.01 0.61 (0.43–0.88) 0.008 0.69 (0.38–1.25) 0.22 0.72 (0.38–1.34) 0.28
Notes: 1 Basic-adjusted model included as covariates age (as continuous) and sex. 2 Fully-adjusted model included as covariates: age (as continuous); sex; race (whites vs. others); body
mass index (as continuous); education (degree vs. others); smoking habits (current and previous vs. others); yearly income (categorized as ≥ or <50,000$ and missing data); Physical
Activity Scale for Elderly score (as continuous); Charlson co-morbidity index (as continuous); daily energy intake (as continuous); adherence to Mediterranean diet (as continuous).
Abbreviations: CI: confidence intervals; OR: odds ratio.
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4. Discussion
In the present cross-sectional study, which included a large group of older adults from North
America, we reported that depressive symptoms were significantly lower in people with higher
dietary vitamin K intake. People in the highest quartile of vitamin K intake (i.e., >232 ug/day)
had significantly lower odds of having depressive symptoms at baseline and each per 100 ug/day
increment was associated with a significant lower odds of this condition of 12%. These findings
remained unaltered after adjustment for potential confounders.
Persons with higher vitamin K intake were more frequently women and they had a higher
physical activity levels, as evaluated with the PASE score. No differences were found regarding
other potential risk factors for depression, such as age, educational level, income, and numbers of
comorbidity. The finding that, in women, dietary intake of vitamin K was higher than in men is not
surprising, since it is widely known that women more frequently consume vegetables and fruits than
men (in our study, for example, women introduced a daily mean of 7.92 ± 4.64 g of vegetable fibers vs.
7.44 ± 4.56, p = 0.001), the major sources of vitamin K [23]. As higher levels of physical activity are
closely related to muscle mass and strength, a better pattern of nutrition probably explains the higher
level of physical activity in the group with higher vitamin K intake [24]. On the other hand, physical
activity itself is an important factor in the prevention of development of depression, as suggested by
a large literature regarding these topics [25–29]. However, we adjusted our analyses for the PASE
score, suggesting that the association between dietary vitamin K and depressive symptoms could be
independent from this factor.
To the best of our knowledge, only one other study evaluated the relationship between the dietary
intake of vitamin K and depression in older adults [5]. According to our findings, Nguyen et al. have
found that, between several vitamins, only a lower vitamin K intake was associated with the presence
of depressive symptoms, both in old men and women [5]. Conversely, no such association was found
in children. This could be related to the difference in the kind of subjects that were enrolled in this
study [11] and because the dietary intake of vitamin K in children is probably too low for reaching a
biological effect. Vitamin K consumption, in fact, is usually doubled in adults than in children [5,11].
Moreover, the sample size that is included is limited to only 710 subjects, which probably leads to a
type II error in their analyses.
Moreover, our findings also resulted in agreement with studies on animals. Rats with vitamin
K-deficiency presented hypoactivity, general malaise, and a lack of exploratory behavior [9]. There is also
an indirect confirmation of our results in humans. Turker et al., for example, found that, in patients under
treatment for atrial fibrillation with warfarin, which is a well-known vitamin K antagonist, the frequency of
depression was significantly higher in period of warfarin use than after dabigatran transition [30].
From a pathophysiological point of view, lifetime low-vitamin K diet in rats is associated with
higher levels of ceramides in the hippocampus [31]. High concentrations of ceramides have been
related to pro-inflammatory processes, the production of reactive oxygen species, and the inhibition of
neuronal survival [31]. A lack of neurogenesis in the hippocampus has been postulated as one of the
possible pathogenetic causes of major depression. Consistent with this hypothesis, it was demonstrated
that some of the antidepressants induce neurogenesis in the hippocampus and inhibit the ceramide
system [32–34]. A meta-analysis on over 1300 subjects found that oxidative stress is increased in
depression [35]. With such premises, we can speculate that a vitamin K supplementation might lower
oxidative stress in the brain and therefore mitigate depressive symptoms.
Our findings have important clinical implications, which extend beyond increasing vitamin K intake
for only depressive symptoms. This is because the consumption of vegetables, particularly green leafy ones,
has been related to a protective effect against cardiovascular disease [36], lower oxidative stress improving
antioxidant status [37], and reduced visceral and liver fat and risk factors for type 2 diabetes [38]. Major
food sources of vitamin K include vegetables, especially green leafy vegetables, vegetable oils, and some
fruits. The most common sources of vitamin K in the United States (U.S.) diet are spinach, broccoli, iceberg
lettuce, and fats and oils, particularly soybean and canola oil [39].
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Finally, another important finding of our research is that vitamin K was associated with depressive
symptoms, only in people not taking vitamin D supplementation. While a recent paper suggest that
vitamin D supplementation might lower vitamin K status [40], in our study, vitamin D supplementation
seems to attenuate the negative effect of a low vitamin K intake. Nevertheless, in our study, another
limitation is the lack of measurement of the uncarboxylated fraction of osteocalcin and matrix gla
protein, markers of vitamin K status, which could better account for the real effect of vitamin K
on depression and bone health. These data indicated that further research is needed to better
elucidate the important issue of the interaction between vitamin D and K that seem to have important
antidepressant effects.
The findings of our work should be interpreted within its limitations. First, the cross-sectional
nature of the work can introduce a reverse causality probability, i.e., people having depression consume
less frequently foods rich of vitamin K, such as vegetables. [41] Second, the OAI only includes people
having knee OA or that are at a high risk of this condition. Thus, further research is needed to see
if our findings can be generalized to the general population. People having knee OA are at higher
risk of depression than the general population, and therefore it is possible that we found stronger
results, since the prevalence of depressive symptomatology is higher than expected [16,42]. However,
in which direction this bias can affect our results is hard to say. Third, vitamin K intake was estimated
by a retrospective self-report of eating habits over one year, and it thus potentially carries itself a
risk of imprecision, inaccuracy, and bias (e.g., social desirability bias). Fourth, information regarding
medications (and in particularly vitamin K antagonists and antidepressants) that might interfere
in the association that we found between vitamin K and depressive symptoms were not included.
Fifth, while there is some debate about whether the effects of different types of vitamin K (i.e., K1 or
K2) have different effects on human health, the data available for this study only allowed for us to
explore relationships with vitamin K as a whole with depressive symptoms [43]. Finally, depressive
mood was only assessed with the CESD scale, whilst the gold standard for the diagnosis of depression
is a structured interview with an expert of this disease.
5. Conclusions
Higher dietary vitamin K intake was significantly associated with a lower presence of depressive
symptoms, also after accounting for potential confounders, suggesting a role for this vitamin in the
prevention and treatment of depressed mood. However, future longitudinal and intervention studies
are needed to confirm or refute our findings.
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